Chairman sang meets with Chris weibach, chairman of pharma board of directors
-
Last Update: 2011-10-19
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: on the afternoon of October 18, 2011, China Council for the promotion of drugs, academician sang Guowei, vice chairman of the Standing Committee of the National People ' )Chris weibach, chairman of the board of directors, vice chairman of the Federation of European pharmaceutical industry associations and CEO of Sanofi Aventis, studied and discussed the theme of "intellectual property protection and innovation and development of pharmaceutical industry" between China and the United States, as well as the cooperation between China and the United States industrial associations Sang pointed out that since 2009, the China Association for the promotion of drugs and the United States Pharma have made positive achievements in exchanges and cooperation He hoped that the "China US pharmaceutical industry summit" would continue to be held regularly in the future as a way to enhance further dialogue and cooperation between the two sides, with an annual focus We should give full play to the role of the two pharmaceutical professional groups as a bridge between the Chinese and American pharmaceutical industries Chris weibach also said that he talked about the issue of intellectual property rights this year and could cooperate on other aspects and topics of interest in the future Chairman sang meets with Chairman Chris wibakhsan of pharma board of directors and Chairman Chris wibach of pharma board of directors
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.